-
-
-
-
-
-
-
Ascendis Pharma (ASND) Tops Q1 EPS by 9c
-
-
-
-
-
-
-
Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
Biotech stocks: Q3 earnings preview
-
-
-
-
-
-
-
Biotech stocks Q1 earnings review
-
-
-
-
-
-
-
Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results
-
-
-
-
-
-
-
Ascendis Pharma (ASND) PT Raised to $160 at TD Cowen
-
-
-
-
-
-
-
Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024
-
1,233,814 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


